Grace TherapeuticsGRCE
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 22 institutions reported holding Grace Therapeutics Inc. (GRCE) in their 13F filings, up 2 from Q3 2025. 6 opened new positions and 4 sold out. The largest holders were Nantahala Capital Management, LLC ($4.1M), AIGH Capital Management LLC ($3.1M) and ADAR1 Capital Management, LLC ($2.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Grace Therapeutics Inc.
- CUSIP
- 00439U104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.7M |
| Exits | 4 | $738K |
All 13F filers, Q3 2025 → Q4 2025: 869,157 shares bought and 247,795 shares sold, net +621,362 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Nantahala Capital Management, LLC | 0.24% | No change | 1,178,203 | $4.1M |
| AIGH Capital Management LLC | 0.93% | No change | 907,217 | $3.1M |
| ADAR1 Capital Management, LLC | 0.17% | Add +83.2% | 641,988 | $2.2M |
| Bank of America Corp. | 0.00% | No change | 494,698 | $1.7M |
| Vanguard Group Inc. | 0.00% | Add +3.6% | 423,981 | $1.5M |
| Cerity Partners LLC | 0.00% | New | 422,732 | $1.5M |
| Renaissance Technologies | 0.00% | Add +53.5% | 129,781 | $449K |
| Citadel Advisors | 0.00% | Add +55.1% | 42,297 | $148K |
| XTX Topco Ltd | 0.00% | New | 30,261 | $106K |
| Morgan Stanley | 0.00% | Add +1277.1% | 25,448 | $88K |
| Gsa Capital Partners LLP | 0.00% | New | 13,774 | $48K |
| Stratos Wealth Partners, LTD. | 0.00% | New | 11,182 | $39K |
| National Bank of Canada | 0.00% | No change | 2,716 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +20.8% | 1,945 | $7K |
| BNP Paribas Financial Markets | 0.00% | New | 600 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -4.9% | 543 | $2K |
| Activest Wealth Management | 0.00% | No change | 104 | $360 |
| SBI Securities Co., Ltd. | 0.00% | No change | 101 | $349 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 41 | $142 |
| Flagship Harbor Advisors, LLC | 0.00% | New | 2 | $7 |
| Lanark Financial, Inc. | 0.00% | No change | 2 | $6 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is GRCE's weight in each manager's 13F, not the share of Grace Therapeutics Inc. the manager owns.